期刊文献+

镍钛合金材料自膨胀式Wingspan支架置入症状性颅内动脉狭窄血管13例1年随访 被引量:3

Nickel-titanium alloy self-expanding Wingspan stent in treatment of intracranial symptomic artery stenosis:One-year follow-up of 13 cases
暂未订购
导出
摘要 背景:Gateway-WingSpan支架系统是2005年通过美国FDA认证,用于治疗症状性颅内动脉狭窄的镍钛合金自膨胀式支架,2007年在中国获得批准正式应用。目的:进一步验证镍钛合金材料自膨胀式Wingspan支架置入治疗症状性脑动脉狭窄的近期疗效及安全性。方法:对13例症状性脑动脉狭窄患者在Gateway球囊预扩下行Wingspan支架置入,狭窄病变18处,其中颈内动脉海绵窦段狭窄4处,大脑中动脉水平段狭窄11处,椎动脉末段狭窄2处,基底动脉下段狭窄1处。狭窄长度5~15mm,平均狭窄(85.3±10.0)%。结果与结论:支架置入成功率100%,置入后即刻造影显示残余狭窄在(30.5±12.0)%;随访12个月,未发生新发卒中或短暂性脑缺血发作,影像学检查显示均无再狭窄发生。13例均未出现与支架有关的动脉夹层、动脉内膜撕裂及急性支架内血栓形成等。均无支架的移位、断裂。支架置入后3d内出现低血压1例,皮下血肿1例,经治疗后症状均消失。结果显示镍钛合金材料自膨胀式Wingspan支架置入治疗症状性脑动脉狭窄比较安全,短期疗效较好。 BACKGROUND:Gateway-Wingspan stent system was certified by the U.S.FDA in 2005 as a nickel-titanium alloy self-expanding stent for the treatment of symptomatic artery stenosis,which was approved to be applied formally in China in 2007.OBJECTIVE:To evaluate the safety and short-term effect of endovascular implantation of nickel-titanium alloy self-expanding Wingspan stent for symptomatic artery stenosis.METHODS:Totally 13 patients with 18 lesions diagnosed as symptomatic artery stenosis were treated with endovascular Wingspan stent based on the Gateway saccule self-expansion.The vascular stenotic lesions involved middle cerebral artery in 11 cases,internal carotid artery in 4 cases,vertebral artery in 2 cases,and basilar artery in 1 case.The length of vascular stenotic lesions was 5-15 mm with a mean incidence of(85.3±10.0)%.RESULTS AND CONCLUSION:All of the 18 stents in the 13 patients were placed successfully in one implantation,accounting for 100%.The stenosis residue was(30.5±12.0)% immediately after implantation;after 12 months follow-up,there was no stroke attack or transient cerebral infarction.The vascular angiography showed no stenosis.After stent implantation,there was no arterial dissection,tear of arterial intima,and acute thrombosis in 13 cases.The stents showed no displacement or rupture.One case appeared to have hypotension and one case had ecchymoma within 3 days after stent implantation,and the symptoms disappeared after treatment.The experimental findings demonstrate that endovascular implantation of nickel-titanium alloy self-expanding Wingspan stent is a safe and effective treatment for intracranial symptomatic artery stenosis,with good short-term efficacy.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第38期7213-7216,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献28

  • 1He J,Sun LJ,Qi XF.Shiyong Zhenduan yu Zhiliao Zazhi.2007; 21(12):952.
  • 2贺娟,孙丽君,齐晓飞.大面积脑梗死60例临床分析[J].实用诊断与治疗杂志,2007,21(12):952-953. 被引量:7
  • 3Chimowitz MI,Lynn MJ,Howlett-Smith H,et al.Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.N Engl J Med.2005;352(13):1305-1316.
  • 4Mazighi M,Tanasescu R,Ducrocq X,et al.Prospective study of symptomatic atherothrombotic intracranial stenoses:the GESICA study.Neurology.2006;66(8):1187-1191.
  • 5Thijs VN,Albers GW.Symptomatic intracranial atherosclerosis:outcome of patients who fail antithrombotic therapy.Neuroloyg.2000;55:490-497.
  • 6Marks MP,Marcellus ML,Do HM,et al.Progression and clinical recurrence of symptomatic atherosclerotic atenosis:long-term follow-up.AJNR Am J Neuroradiol.2005;26:525-530.
  • 7Jiang WJ,Wang YJ,Du B,et al.Stenting of symptomatic Ml stenosis of middle cerebral artery:an initial experience of 40 patients.Stroke.2004;35:1375-1380.
  • 8Kim KJ,Ahn JY,Lee BH,et al.Stenting of symptomatic Ml stenosis of middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks:short term arteriogtaphical and clinical outcome.J Neurol Neurosurg Psychiatry.2004;75:847-851.
  • 9Wang DM.Zhonghua Laonian Xinxueguanbing Zazhi.2007;9(7):433-437.
  • 10王大明.症状性颅内动脉狭窄的血管内治疗[J].中华老年心脑血管病杂志,2007,9(7):433-434. 被引量:12

二级参考文献106

共引文献363

同被引文献38

  • 1方淳,李明华,赵俊功,孙晓江,程英升,王武.动、静脉结合r-tPA溶栓治疗早期脑梗死[J].介入放射学杂志,2005,14(5):452-456. 被引量:6
  • 2马如钧,刘建民,黄清海,洪波,许奕,赵文元,赵瑞,陈军.药物洗脱支架治疗椎基底动脉狭窄[J].介入放射学杂志,2006,15(11):643-647. 被引量:8
  • 3Bogousslav sky J , Barnett H J M, Fox A J , et al. A therosclerot- ic disease of the middle cerebra 1 artery [ J]. Stroke, 1986, (17) : 12-22.
  • 4Higashida RT, Meyers PM, Connors JJ 3rd, et al. Intracranial an- gioplasty & stenting for cerebral atherosclerosis: a position state- ment of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the Amer- ican Society of Neuroradiology [ J ]. AJNR Am J Neuroradiol, 2005,26(9) :2323-2327.
  • 5Marks MP, Marcellus ML, Do HM, et al. Intraeranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up [ J]. AJNR Am J Neumradiol, 2005,26(3) :525-530.
  • 6Chimowitz MI, Lynn M J, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis [J]. N Engl J Med, 2005,352(13) :1305-1316.
  • 7Henkes H, Miloslavski E, Lowens S, et al. Treatment of intracra- nial atherosclerotic stenoses with balloon dilatation and self-expan- ding stent deployment (WingSpan) [ J ]. Neuroradiology, 2005, 47 ( 3 ) :222-228.
  • 8Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclemtic steno- ses: the Wingspan study [J]. Stroke, 2007,38(5):1531-1537.
  • 9Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 ste- nosis of middle cerebral artery: an initial experience of 40 patients [J]. Stroke, 2004,35(6) :1375-1380.
  • 10Fiorella D, Levy EI, Turk AS, et al. US muhicenter experience with the wingspan stent system for the treatment of intracranial ath- eromatous disease : pefiprocedural results [ J ]. Stroke, 2007,38 (3) :881-887.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部